Detheux Michel

Detheux Michel is listed in filings as Chief Executive Officer at iTeos Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 29, 2025, including sale activity. Recent filings connect the profile to iTeos Therapeutics, Inc. (ITOS) and Vor Biopharma Inc. (VOR). The current snapshot covers public activity from Aug 9, 2024 to Aug 29, 2025. Reported amounts are shown as $3.1M to $784.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.